JP2023535026A5 - - Google Patents
Info
- Publication number
- JP2023535026A5 JP2023535026A5 JP2023504288A JP2023504288A JP2023535026A5 JP 2023535026 A5 JP2023535026 A5 JP 2023535026A5 JP 2023504288 A JP2023504288 A JP 2023504288A JP 2023504288 A JP2023504288 A JP 2023504288A JP 2023535026 A5 JP2023535026 A5 JP 2023535026A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- group
- salt
- agent
- heteroatoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063055308P | 2020-07-22 | 2020-07-22 | |
| US63/055,308 | 2020-07-22 | ||
| US202163208494P | 2021-06-08 | 2021-06-08 | |
| US63/208,494 | 2021-06-08 | ||
| PCT/US2021/042856 WO2022020652A2 (en) | 2020-07-22 | 2021-07-22 | Stapled peptides and methods thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023535026A JP2023535026A (ja) | 2023-08-15 |
| JP2023535026A5 true JP2023535026A5 (https=) | 2024-08-08 |
Family
ID=79728982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504288A Pending JP2023535026A (ja) | 2020-07-22 | 2021-07-22 | ステープルペプチドおよびその方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240116985A1 (https=) |
| EP (1) | EP4185599A4 (https=) |
| JP (1) | JP2023535026A (https=) |
| KR (1) | KR20230057350A (https=) |
| CN (1) | CN116323638A (https=) |
| AU (1) | AU2021314310A1 (https=) |
| CA (1) | CA3186681A1 (https=) |
| IL (1) | IL299907A (https=) |
| MX (1) | MX2023000947A (https=) |
| WO (1) | WO2022020652A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018329956A1 (en) | 2017-09-07 | 2020-08-20 | Fog Pharmaceuticals, Inc. | Agents modulating beta-catenin functions and methods thereof |
| MX2021001943A (es) | 2018-08-20 | 2021-07-15 | Fog Pharmaceuticals Inc | Colecciones de péptidos, agentes peptídicos y métodos de uso de los mismos. |
| KR20240031957A (ko) * | 2021-06-08 | 2024-03-08 | 포그 파마슈티컬스 인코포레이티드 | 스테이플화된 펩티드 및 이의 방법 |
| CN115260060A (zh) * | 2022-09-07 | 2022-11-01 | 康化（上海）新药研发有限公司 | (2s)-2-n-芴甲氧羰基氨基-5,5-二甲基正亮氨酸的合成方法 |
| WO2024054892A1 (en) * | 2022-09-09 | 2024-03-14 | Shape Therapeutics Inc. | Therapeutic peptides |
| WO2024130217A1 (en) * | 2022-12-15 | 2024-06-20 | Fog Pharmaceuticals, Inc. | Stapled peptides and methods thereof |
| CN120529912A (zh) * | 2022-12-15 | 2025-08-22 | 帕拉比利斯药物公司 | 订书钉化肽及其方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5671196A (en) * | 1996-03-28 | 1997-10-17 | Immulogic Pharmaceutical Corporation | Myelin oligodendrocyte glycoprotein peptides and uses thereof |
| US20040181830A1 (en) * | 2001-05-07 | 2004-09-16 | Kovalic David K. | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| US20050187147A1 (en) * | 2003-09-22 | 2005-08-25 | Newman Michael J. | Compositions and methods for increasing drug efficiency |
| EP2254592B1 (en) * | 2008-02-28 | 2019-06-05 | Dako Denmark A/S | Mhc multimers in borrelia diagnostics and disease |
| WO2010009987A2 (en) * | 2008-07-21 | 2010-01-28 | Probiodrug Ag | Diagnostic antibody assay |
| EP2337795A2 (en) * | 2008-10-01 | 2011-06-29 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| WO2012040459A2 (en) * | 2010-09-22 | 2012-03-29 | President And Fellows Of Harvard College | Beta-catenin targeting peptides and uses thereof |
| WO2014026033A1 (en) * | 2012-08-08 | 2014-02-13 | University Of Florida Research Foundation, Inc. | Cross-reactive t cell epitopes of hiv, siv, and fiv for vaccines in humans and cats |
| GB2563875B (en) * | 2017-06-28 | 2020-08-19 | Sutura Therapeutics Ltd | Improvements in drug delivery |
| AU2018329956A1 (en) * | 2017-09-07 | 2020-08-20 | Fog Pharmaceuticals, Inc. | Agents modulating beta-catenin functions and methods thereof |
| WO2019178313A1 (en) * | 2018-03-14 | 2019-09-19 | Dana-Farber Cancer Institute, Inc. | Stabilized peptides for biomarker detection |
-
2021
- 2021-07-22 AU AU2021314310A patent/AU2021314310A1/en not_active Abandoned
- 2021-07-22 JP JP2023504288A patent/JP2023535026A/ja active Pending
- 2021-07-22 WO PCT/US2021/042856 patent/WO2022020652A2/en not_active Ceased
- 2021-07-22 CA CA3186681A patent/CA3186681A1/en active Pending
- 2021-07-22 IL IL299907A patent/IL299907A/en unknown
- 2021-07-22 MX MX2023000947A patent/MX2023000947A/es unknown
- 2021-07-22 KR KR1020237005577A patent/KR20230057350A/ko active Pending
- 2021-07-22 CN CN202180064601.7A patent/CN116323638A/zh active Pending
- 2021-07-22 US US18/017,024 patent/US20240116985A1/en active Pending
- 2021-07-22 EP EP21847152.2A patent/EP4185599A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023535026A5 (https=) | ||
| JP6956967B2 (ja) | Ｗｔ１抗原ペプチドおよび免疫調節剤の併用 | |
| TWI823054B (zh) | IL-7Rα結合化合物 | |
| JP5295785B2 (ja) | 細胞膜透過性ペプチド | |
| TWI750725B (zh) | 新穎脂肪酸及其於共軛至生物分子之用途 | |
| TWI812918B (zh) | IL-7Rαγc結合化合物 | |
| JP2016523275A (ja) | 多様な疾患を処置するためのｊｎｋ阻害剤分子の新規な用途 | |
| JP2024522368A5 (https=) | ||
| Hutchinson et al. | The effect of lipidation on the self-assembly of the gut-derived peptide hormone PYY3–36 | |
| KR20230075530A (ko) | 분지형 링커를 갖는 튜불리신 유사체의 접합체 | |
| AU2016287754A1 (en) | Stabilized anti-microbial peptides | |
| DK2806896T3 (en) | Chitosan covalently bound to small molecule integrin antagonist for targeted delivery | |
| JP2010174013A (ja) | 組織ダメージの治療と予防 | |
| CA3160466A1 (en) | Dual il-2r and il-7r binding compounds | |
| JP2005531559A5 (https=) | ||
| US20140155313A1 (en) | Hydrogels with covalently linked polypeptides | |
| JPWO2018181648A1 (ja) | Ｗｔ１癌抗原ペプチドおよびこれを含むペプチドコンジュゲート体 | |
| KR20230009426A (ko) | 암을 처치하기 위한 의약 조성물 | |
| Redman et al. | Pharmacokinetic and chemical synthesis optimization of a potent D-peptide HIV entry inhibitor suitable for extended-release delivery | |
| CA3197344A1 (en) | Il-2r.beta.yc binding compounds and uses thereof | |
| US20130337050A1 (en) | Drug Transporter Permeating Blood-Brain Barrier, Peptide and Use Thereof | |
| Yoong et al. | Mitochondria-acting hexokinase II peptides carried by short-length carbon nanotubes with increased cellular uptake, endosomal evasion, and enhanced bioactivity against cancer cells | |
| Yang et al. | Self-Assembling Hydrogels of Naproxen-Conjugated Peptides for Osteoarthritis Treatment | |
| JPWO2019131722A1 (ja) | Ｗｔ１由来ペプチドのコンジュゲート体およびこれを含む組成物 | |
| CN109069577B (zh) | Hiv进入的d-肽抑制剂以及使用方法 |